FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385102005: Conventional release cutaneous paste (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479364011 Cutaneous paste en Synonym Active Entire term case insensitive SNOMED CT core module
3541119019 Conventional release cutaneous paste en Synonym Active Entire term case insensitive SNOMED CT core module
3541121012 Conventional release cutaneous paste (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous paste Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Is a Drug paste false Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Has basic dose form Paste true Inferred relationship Existential restriction modifier
Conventional release cutaneous paste Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zinc+salicylic acid paste half strength Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Perfluoroalkylpolyether 50%/polytetrafluoroethylene 50% 84g topical paste Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Titanium dioxide 20% paste Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Aluminum oxide 52.2% paste Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Product containing precisely aluminium oxide 381 milligram/1 gram conventional release cutaneous paste (clinical drug) Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Perfluoroalkylpolyether 50%/polytetrafluoroethylene 50% topical paste Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Product containing precisely aluminium oxide 381 milligram/1 gram conventional release cutaneous paste (clinical drug) Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Product containing precisely aluminium oxide 381 milligram/1 gram conventional release cutaneous paste (clinical drug) Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier
Product containing precisely aluminium oxide 381 milligram/1 gram conventional release cutaneous paste (clinical drug) Has manufactured dose form False Conventional release cutaneous paste Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start